Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Ashish Bhatia MD, FAAD

Ashish C. Bhatia MD, FAAD

Associate Professor of Clinical Dermatology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois; Co-Founder, Director of Clinical Research, and Co-Director, Dermatologic, Laser and Cosmetic Surgery, Oak Dermatology, Itasca, Joliet, and Naperville, Illinois

Dr. Ashish Bhatia is a board-certified and fellowship-trained dermatologist and dermatologic surgeon. He is an Associate Professor of Clinical Dermatology at Northwestern University Feinberg School of Medicine in Chicago and the Director of Dermatologic, Laser, and Cosmetic Surgery at Oak Dermatology (locations in Itasca, Joliet, and Naperville, Illinois).

Dr. Bhatia is a recognized expert in dermatologic surgery and cosmetic surgery. His clinical expertise includes Mohs and reconstructive surgery, skin cancer therapy and prevention, laser surgery, skin resurfacing procedures, and cosmetic procedures including lasers, fillers, and neuromodulators. He also has a special interest in restorative procedures for adults and children with burns, surgical scars, and traumatic scars.

After receiving his medical degree from Northeastern Ohio University College of Medicine, Dr. Bhatia completed his residency in dermatology at the Medical College of Virginia Hospitals, where he served as Chief Resident. Subsequently, he completed an intensive fellowship in Mohs surgery, cutaneous oncology, and reconstruction, cosmetic, and laser surgery at SkinCare Physicians in Boston, Massachusetts.

Disclosures

  • Grants/research: AbbVie; Alastin Skincare; Avita Medical; Cutera; Medline; NovaScan; Pulse Biosciences; R2 Technologies; Revance
  • Consulting/advisory boards: Alastin Skincare; Allergan/AbbVie; Arcutis; Avita Medical; Bausch Health; Carpe; Cutera; Cytrellis; Emblation Ltd; Endo Aesthetics; Entrepix Medical; Evolus; Medline; MiMEDx; Obagi; Ortho Dermatologics; RBC Consultants; Revance; Solta; Sofwave; Strata Skin Sciences; Theravant Corp
  • Speaker bureau: Allergan; Cutera; DermEd Foundation; Evolus; Medline; MiMEDx; Ortho Dermatologics; Paradigm Medical; Revance; Theravant Corp
  • Ownership interest/shareholder: Biomarck; Carpe; Cutera; Derma MD; Genzum; SimSkin; Sonoma; Theravant Corp; Zalea
  • Stock/options: AbbVie; Bausch Health; Biomarck; Carpe; Cutera; Cytrellis; Strata Skin Health
  • Executive role/board member: Theravant Corp; DermEd Foundation

Recent Contributions to PracticeUpdate:

  1. Anecdote Increases Patient Willingness to Take a Biologic Medication
  2. Cutaneous Reactions After SARS-CoV-2 Vaccination
  3. Opioid Prescriptions Obtained After Mohs Surgery
  4. Successful Treatment of DSAP With Topical 2% Cholesterol/2% Lovastatin
  5. Tangential Excision of Small BCCs and SCCs With Formalin Horizontal Margin Histopathologic Evaluation
  6. Topical 5% 5-Fluorouracil Versus Procedural Modalities for Squamous Cell Carcinoma In Situ and Superficial Basal Cell Carcinoma
  7. Topical Corticosteroid Use Is Not Associated With Fracture Risk Among Children With Atopic Dermatitis
  8. COVID-19 Vaccine-Induced Stevens–Johnson Syndrome
  9. Psoriasis Exacerbation After COVID-19 Vaccination
  10. Clinical Determinants of Complete Response to Vismodegib in Locally Advanced Basal Cell Carcinoma

Elsewhere

Most Read This Week

Recently Updated